Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
ZLN024 increases the activity of α1β1γ1 by 1
7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h11
Cobalt chloride induces RhoA/ROCK activation and remodeling effect in H9c2 cardiomyoblasts: Involvement of PI3K/Akt and MAPK pathways
36(1-2):127-35
InChi: InChI=1S/C78H98N4O20/c1-13-57(53-43-67(93-7)73(97-11)68(44-53)94-8)75(85)81-37-17-15-25-59(81)77(87)101-61(31-27-49-29-33-63(89-3)65(39-49)91-5)51-21-19-23-55(41-51)99-47-71(83)79-35-36-80-72(84)48-100-56-24-20-22-52(42-56)62(32-28-50-30-34-64(90-4)66(40-50)92-6)102-78(88)60-26-16-18-38-82(60)76(86)58(14-2)54-45-69(95-9)74(98-12)70(46-54)96-10/h19-24
CCG-63802 - CAS# 620112-78-9 Catalog No.:M10963-2 ZLN024 increases the activity ofCCG 63802 is a potent and reversible inhibitor of RGS protein. CCG 63802 inhibits the interaction between RGS4 and Galpha(o) with an IC(50) value in the low micromolar range. CCG 63802 shows selectivity among RGS proteins with a potency order of RGS 4 > 19 = 16 > 8 >> 7. CCG 63802 inhibits the GTPase accelerating protein activity of RGS4, and thermal stability studies demonstrate binding to the RGS but not to Galpha(o). CCG 63802 represents a useful
US$ 260.10
US$ 75.00
US$ 118.00
US$ 88.00
US$ 38.00
US$ 38.00
US$ 566.85
US$ 88.00
US$ 85.00
US$ 38.00